• https://www.databridgemarketresearch.com/reports/global-pancreatic-cancer-diagnostics-market
    https://www.databridgemarketresearch.com/reports/global-pancreatic-cancer-diagnostics-market
    0 Kommentare 0 Anteile 53 Ansichten 0 Vorschau
  • https://www.databridgemarketresearch.com/reports/global-pancreatic-cancer-diagnostics-market
    https://www.databridgemarketresearch.com/reports/global-pancreatic-cancer-diagnostics-market
    Pancreatic Cancer Diagnostics Market Size, Trends, Growth Report 2032
    The Global Pancreatic Cancer Diagnostics Market was valued at USD 3.00 Billion in 2023 and is expected to reach USD 5.35 Billion by 2032, growing at a CAGR of 7.5% (2024-2032).
    0 Kommentare 0 Anteile 60 Ansichten 0 Vorschau
  • Tubular Metal Biliary Stents Market to Reach USD 510 Million by 2034

    According to a newly published market research report by 24LifeSciences, global tubular metal biliary stents market is valued at USD 337 million in 2026 and is projected to reach USD 510 million by 2034, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period.

    Tubular metal biliary stents are self-expanding metallic mesh devices primarily used to maintain bile duct patency in patients suffering from malignant obstructions caused by pancreatic cancer or cholangiocarcinoma, as well as benign strictures. These minimally invasive implants are deployed via endoscopic retrograde cholangiopancreatography (ERCP) procedures to relieve jaundice, prevent life-threatening cholangitis, and significantly improve patients' quality of life. The market is primarily segmented into covered stentswhich feature a polymer membrane to prevent tumor ingrowthand uncovered stents, each offering distinct clinical advantages for specific patient populations.

    Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10403/tubular-metal-biliary-stents-market
    Tubular Metal Biliary Stents Market to Reach USD 510 Million by 2034 According to a newly published market research report by 24LifeSciences, global tubular metal biliary stents market is valued at USD 337 million in 2026 and is projected to reach USD 510 million by 2034, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period. Tubular metal biliary stents are self-expanding metallic mesh devices primarily used to maintain bile duct patency in patients suffering from malignant obstructions caused by pancreatic cancer or cholangiocarcinoma, as well as benign strictures. These minimally invasive implants are deployed via endoscopic retrograde cholangiopancreatography (ERCP) procedures to relieve jaundice, prevent life-threatening cholangitis, and significantly improve patients' quality of life. The market is primarily segmented into covered stentswhich feature a polymer membrane to prevent tumor ingrowthand uncovered stents, each offering distinct clinical advantages for specific patient populations. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10403/tubular-metal-biliary-stents-market
    0 Kommentare 0 Anteile 17 Ansichten 0 Vorschau